The Fontan Procedure and Its Hepatic Complications: Understanding Fontan-Associated Liver Disease (FALD)
1️⃣ What Is the Fontan Procedure?
The Fontan procedure is a palliative cardiac surgery performed for children with single-ventricle congenital heart defects, where only one ventricle is capable of supporting systemic circulation.
➤ Purpose:
To separate systemic and pulmonary circulation in patients who cannot undergo a biventricular repair.
➤ Indications:
Common congenital heart diseases requiring Fontan include:
- Tricuspid atresia
- Hypoplastic left heart syndrome (HLHS)
- Double inlet left ventricle
- Pulmonary atresia with intact ventricular septum
- Unbalanced atrioventricular septal defect
2️⃣ The Principle of the Fontan Circulation
In a normal heart, the right ventricle pumps deoxygenated blood to the lungs, and the left ventricle pumps oxygenated blood to the body.But in a single-ventricle heart, one ventricle must handle both circuits, which is not sustainable.
➤ The Fontan Solution:
The Fontan operation bypasses the right ventricle by routing systemic venous blood directly into the pulmonary arteries, allowing passive flow into the lungs.
🩸 Surgical Concept:
- Systemic veins (SVC + IVC) → directly connected to pulmonary arteries
- The single ventricle → pumps only oxygenated blood to systemic circulation
Thus, the Fontan circulation is non-pulsatile, passive, and depends entirely on pressure gradients between the systemic venous and pulmonary arterial systems.
3️⃣ Why We Do It (Clinical Necessity)
The Fontan procedure is not curative — it is a palliative repair designed to: ✅ Separate oxygenated and deoxygenated blood ✅ Improve systemic oxygen saturation (reduces cyanosis) ✅ Reduce ventricular volume overload ✅ Allow better growth and exercise tolerance ✅ Increase survival into adulthood
Without this surgery, children with single-ventricle physiology typically die early from hypoxia or heart failure.
4️⃣ The Downside: The Fontan Physiology
While life-saving, the Fontan circulation creates chronic systemic venous hypertension and low cardiac output.
⚠️ Key Hemodynamic Features:
- No sub-pulmonary pump (right ventricle bypassed)
- Passive pulmonary blood flow → dependent on low PVR
- Chronically elevated central venous pressure (CVP ≈ 12–18 mmHg)
- Reduced preload → limited cardiac output
This non-physiologic circulation places constant stress on organs, especially the liver, lymphatics, and intestines.
5️⃣ Chronic Hepatic Congestion and Fontan-Associated Liver Disease (FALD)
➤ What is FALD?
Fontan-Associated Liver Disease (FALD) is a spectrum of chronic liver injury resulting from long-standing elevated systemic venous pressure and low cardiac output after a Fontan operation.It is essentially a form of congestive hepatopathy progressing to fibrosis and cirrhosis.
6️⃣ Pathophysiology of FALD
🧬 Step-by-Step Mechanism:
- Chronically elevated central venous pressure (CVP)→ Causes hepatic venous congestion because the hepatic veins drain into the systemic venous system.
- Sinusoidal congestion and dilatation→ Leads to hepatocyte atrophy around the central veins (centrilobular necrosis).
- Chronic hypoxia and low cardiac output→ Reduce hepatic perfusion and oxygen delivery, worsening injury.
- Repeated injury and repair cycle→ Triggers fibrosis starting in zone 3 (centrilobular), extending to bridging fibrosis.
- Development of nodular regenerative hyperplasia (NRH)→ From uneven perfusion and chronic hypoxia, producing a cirrhotic pattern even without classic portal hypertension.
- Over time, this progresses to:
- Cardiac cirrhosis
- Portal hypertension
- Ascites
- Hepatocellular carcinoma (HCC) risk
⚠️ Important Note:
Unlike viral or alcoholic cirrhosis, FALD occurs even with normal hepatic enzymes. Thus, liver fibrosis may progress silently for 10–20 years after the Fontan procedure.
7️⃣ What Happens Next — Clinical Course
| Stage | Description | Findings |
| Early FALD | Hepatic congestion & mild fibrosis | Mildly elevated LFTs, hepatomegaly |
| Established FALD | Bridging fibrosis & NRH | Portal hypertension, splenomegaly, ascites |
| End-stage FALD | Cirrhosis ± HCC | Decompensated liver disease |
8️⃣ How to Detect and Monitor FALD Early
🧪 Screening & Diagnostic Tools
| Test | Purpose |
| Liver function tests (LFTs) | May remain normal until advanced disease |
| Ultrasound with Doppler | Detects hepatomegaly, congestion, ascites |
| Elastography (FibroScan) | Measures liver stiffness (fibrosis proxy) |
| MRI with contrast | Identifies fibrosis pattern & regenerative nodules |
| Liver biopsy | Gold standard, but risky — reserved for unclear cases |
| Alpha-fetoprotein (AFP) | HCC surveillance |
9️⃣ Can We Prevent or Reverse FALD?
Unfortunately, true prevention is not possible, but progression can be slowed with proper management and early detection.
🛡️ Strategies to Protect the Liver in Fontan Patients:
1. Optimize Fontan Hemodynamics
- Maintain low pulmonary vascular resistance (PVR)
- Avoid hypoxia, hypercapnia, acidosis
- Treat respiratory infections promptly
- Avoid dehydration (reduces venous flow)
- Manage arrhythmias and heart failure aggressively
2. Control Venous Congestion
- Use diuretics carefully to prevent fluid overload but avoid excessive volume depletion.
- ACE inhibitors or beta-blockers may be used to optimize cardiac function.
3. Anticoagulation
- Reduces risk of hepatic and systemic thrombosis, which can worsen hepatic congestion.
4. Regular Surveillance
- Liver ultrasound every 6–12 months
- Elastography every 1–2 years
- AFP + imaging for HCC screening (especially after 10 years post-Fontan)
5. Multidisciplinary follow-up
- Involves cardiology, hepatology, and radiology teams.
6. Liver transplantation or combined heart-liver transplant
- Indicated in end-stage FALD or Fontan failure with cirrhosis.
🔟 Key Takeaways
| Concept | Summary |
| Fontan circulation | Routes venous blood directly to lungs, bypassing right ventricle |
| Hemodynamic feature | High venous pressure, low cardiac output |
| FALD | Chronic congestive hepatopathy → fibrosis → cirrhosis |
| Main driver | Chronic hepatic congestion and hypoperfusion |
| Prevention | Not fully preventable, but progression can be delayed |
| Surveillance | Lifelong liver imaging and functional monitoring |
| Treatment | Optimize Fontan physiology; transplant for end-stage disease |
Clinical Pearl
“Fontan-associated liver disease is the inevitable price of Fontan physiology — not a complication of surgery but a consequence of survival.”
Comments
No comments yet. Be the first to share your thoughts.
Sign in to comment